Your browser doesn't support javascript.
loading
The Impact of Compliance During Exclusive Enteral Nutrition on Faecal Calprotectin in Children With Crohn Disease.
Mckirdy, Shona; Russell, Richard K; Svolos, Vaios; Gkikas, Konstantinos; Logan, Michael; Hansen, Richard; Gerasimidis, Konstantinos.
Afiliação
  • Mckirdy S; Human Nutrition, School of Medicine, Dentistry and Life Sciences, university of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow.
  • Russell RK; Department of Paediatric Gastroenterology, Royal Hospital for Children & Young People, Edinburgh.
  • Svolos V; Human Nutrition, School of Medicine, Dentistry and Life Sciences, university of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow.
  • Gkikas K; Human Nutrition, School of Medicine, Dentistry and Life Sciences, university of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow.
  • Logan M; Human Nutrition, School of Medicine, Dentistry and Life Sciences, university of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow.
  • Hansen R; Department of Paediatric Gastroenterology, Royal Hospital for Children, Glasgow, UK.
  • Gerasimidis K; Human Nutrition, School of Medicine, Dentistry and Life Sciences, university of Glasgow, New Lister Building, Glasgow Royal Infirmary, Glasgow.
J Pediatr Gastroenterol Nutr ; 74(6): 801-804, 2022 06 01.
Article em En | MEDLINE | ID: mdl-35192573
ABSTRACT
ABSTRACT It remains unclear whether suboptimal response to exclusive enteral nutrition (EEN) in some children with Crohn disease (CD) is explained by poor compliance. The present study measured faecal gluten immunogenic peptides (GIP), a biomarker of gluten intake, in 45 children (3- 17 years) with CD, and explored associations with faecal calprotectin (FC) levels at 33 and 54 days of EEN. FC decreased in patients with undetectable GIP at both 33 and 54 days of EEN (mean decrease, 33 days -743 mg/kg, 54 days -1043 mg/kg, P  < 0.001) but not in patients who had detectable levels. At EEN completion, patients with undetectable GIP had a lower FC by 717 mg/kg compared with patients with a positive GIP result (P = 0.042) and demonstrated a greater decline from baseline FC (-69% vs +5%, P = 0.011). Poorer response to EEN is explained in part by diminished compliance. Faecal GIP might be useful as proxy biomarker of EEN compliance.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Cooperação do Paciente / Complexo Antígeno L1 Leucocitário Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn / Cooperação do Paciente / Complexo Antígeno L1 Leucocitário Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article